VIR
Vir Biotechnology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$10.60
−2.93%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- -$0.74
- Revenue estimate
- $865.1K
Latest reported
- Last report date
- Aug 5, 2026
- EPS actual
- $0.47
- EPS estimate
- $0.33
- Revenue actual
- $238.9M
- Revenue estimate
- $135.9M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -2099.9%
- Revenue beats (12Q)
- 5
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 5, 2026 | $0.33 | $0.47 | Beat 41.31% | $238.9M |
| May 6, 2026 | -$0.01 | -$0.85 | Miss -8400.00% | -$29.0K |
| Feb 23, 2026 | -$0.42 | -$0.31 | Beat 26.19% | $64.1M |
| Nov 5, 2025 | -$0.70 | -$1.17 | Miss -67.14% | — |
| Feb 26, 2025 | -$0.85 | -$0.76 | Beat 10.59% | $12.4M |
| Oct 31, 2024 | -$0.96 | -$1.56 | Miss -62.50% | $2.4M |
| Aug 1, 2024 | -$0.93 | -$1.02 | Miss -9.68% | $3.1M |
| May 2, 2024 | -$0.99 | -$0.48 | Beat 51.52% | $56.4M |
| Feb 22, 2024 | -$1.14 | -$0.86 | Beat 24.56% | $16.8M |
| Nov 2, 2023 | -$1.21 | -$1.22 | Miss -0.83% | $4.1M |
| Aug 3, 2023 | -$1.21 | -$1.45 | Miss -19.83% | $12.7M |
| May 4, 2023 | -$0.81 | -$1.06 | Miss -30.86% | $46.7M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026